National Alliance on Mental Illness http://www.nami.org
National Institute of Neurological Disorders and Stroke http://www.ninds.nih.gov
Canadian Mental Health Association http://www.ontario.cmha.ca
Mental Health Canada http://www.mentalhealthcanada.com
Bai YM, Yu SC, et al.
Risperidone for severe tardive dyskinesia: A 12-week randomized, double-blind, placebo-controlled study.
J Clin Psychiatry. 2003;64(11):1342-1348.
Damier P. Drug-induced dyskinesias.
Curr Opin Neurol. 2009;22(4):394-399.
Kinon BJ, Jeste DV, et al.
Olanzapine treatment for tardive dyskinesia in schizophrenia patients: a prospective clinical trial with patients randomized to blinded dose reduction periods.
Prog Neuropsychopharmacol Biol Psychiatry. 2004;28(6):985-996.
McGrath JJ, Soares KV. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
Database Syst Rev. 2006;(1):CD000459.
Meco G, Fabrizio E, et al. Levetiracetam in tardive dyskinesia.
Clin Neuropharmacol. 2006;29(5):265-268.
Pham DQ, Plakogiannis R. Vitamin E supplementation in Alzheimer’s disease, Parkinson’s disease, tardive dyskinesia, and cataract: Part 2.
Ann Pharmacother. 2005;39(12):2065-2072.
Sachdev PS. The current status of tardive dyskinesia.
Australian and New Zealand Journal of Psychiatry. 2000;34(3):355-369.
Soares KV, McGrath JJ. The treatment of tardive dyskinesia: A systematic review and meta-analysis.
Tardive dyskinesia. EBSCO DynaMed website. Available at:
http://www.ebscohost.com/dynamed. Updated November 23, 2011. Accessed July 29, 2013.
Thema B, Srivastava V, et al. Genetic underpinnings of tardive dyskinesias: passing the baton to pharmacogenetics.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
Copyright © 2012 EBSCO Publishing
All rights reserved.
It's time to stop guessing. If you want to make some changes but just aren't sure how, the free personal health survey from LiveWell is a great place to start.
Fight heart disease and prevent heart attacks. HeartSHAPE® is a painless, non-invasive test that checks pictures of your heart for early-stage coronary disease.
How many calories do you need to eat each day to maintain your weight and fuel your physical activity? Enter a few of your stats into this calculator to find out.
Using body mass index as a reference, this calculator determines your ideal body weight range. All you need to do is enter your height.
This tool considers your height and weight to assess your weight status.
Wellmont Nurse Connection is your resource for valuable health information any time, 24 hours a day, seven days a week. Speak to a Nurse any time, day or night, at (423) 723-6877 or toll-free at 1-877-230-NURSE.
You clicked on a link that will cause you to leave myWellmont.
For security purposes you will be signed out.